Clinical Trial Update: Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199 [Phase 2]

View source ↗

Summary

A Phase 2 single-dose crossover study assessing the pharmacodynamics of AZD3199 in asthma and airway obstruction; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airway Obstruction
• Asthma

Drugs mentioned

• AZD3199

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Airway Obstruction | Phase 2 | Status: COMPLETED | Results posted: 2014-04-03